comparemela.com

Latest Breaking News On - Hospital cancer center - Page 4 : comparemela.com

ESR1-Driven Resistance to CDK4/6 Inhibitors in Breast Cancer Thwarted by SERDs

Sermonix to Host KOL Fireside Chat on Advancements in the Metastatic Breast Cancer Treatment Landscape on April 22, 2024

COLUMBUS, Ohio, April 19, 2024 (GLOBE NEWSWIRE) Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers (mBC)

Andrew E Place, MD, PhD appointed as Dana-Farber/Boston Children s Cancer and Blood Disorders Center Vice President, Pediatric Chief Medical Officer

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.